- Home
- CLLS vs OGI Comparison
CLLS vs OGI Comparison
Compare CLLS & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- OGI
- Stock Information
- Founded
- CLLS 1999
- OGI 2013
- Country
- CLLS France
- OGI Canada
- Employees
- CLLS N/A
- OGI N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- CLLS Health Care
- OGI Health Care
- Exchange
- CLLS Nasdaq
- OGI Nasdaq
- Market Cap
- CLLS 240.2M
- OGI 191.1M
- IPO Year
- CLLS 2007
- OGI N/A
- Fundamental
- Price
- CLLS $1.91
- OGI $1.74
- Analyst Decision
- CLLS Buy
- OGI
- Analyst Count
- CLLS 2
- OGI 0
- Target Price
- CLLS $8.00
- OGI N/A
- AVG Volume (30 Days)
- CLLS 25.4K
- OGI 307.9K
- Earning Date
- CLLS 11-04-2024
- OGI 12-17-2024
- Dividend Yield
- CLLS N/A
- OGI N/A
- EPS Growth
- CLLS N/A
- OGI N/A
- EPS
- CLLS N/A
- OGI N/A
- Revenue
- CLLS $19,635,000.00
- OGI $110,297,722.00
- Revenue This Year
- CLLS $271.02
- OGI $8.76
- Revenue Next Year
- CLLS $33.48
- OGI $14.04
- P/E Ratio
- CLLS N/A
- OGI N/A
- Revenue Growth
- CLLS N/A
- OGI 2.33
- 52 Week Low
- CLLS $0.96
- OGI $0.97
- 52 Week High
- CLLS $3.77
- OGI $2.91
- Technical
- Relative Strength Index (RSI)
- CLLS 36.61
- OGI 47.68
- Support Level
- CLLS $1.95
- OGI $1.70
- Resistance Level
- CLLS $2.06
- OGI $1.80
- Average True Range (ATR)
- CLLS 0.10
- OGI 0.07
- MACD
- CLLS -0.01
- OGI 0.00
- Stochastic Oscillator
- CLLS 9.37
- OGI 42.31
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.